Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michael D. Otremba, M.D.

Concepts (71)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cranial Fossa, Anterior12013130.450 Why?
Prisons120151600.440 Why?
Hospital Charges120153570.430 Why?
Otitis12012200.410 Why?
Mastoiditis12012360.400 Why?
Agammaglobulinemia120121710.360 Why?
Maxilla120134800.350 Why?
Skull Base Neoplasms120132690.340 Why?
Antibodies, Monoclonal, Murine-Derived120126920.320 Why?
Immunoglobulins, Intravenous120126530.290 Why?
Poverty1201526100.220 Why?
Developing Countries1201528040.210 Why?
Parathyroid Glands120225200.180 Why?
Neoplasms, Unknown Primary120181020.150 Why?
Neck Dissection120181990.140 Why?
Papillomavirus Infections2201815820.130 Why?
Radiotherapy, Adjuvant2201817680.130 Why?
Thyroid Gland1202211660.130 Why?
Patient Credit and Collection12015160.130 Why?
Salivary Gland Neoplasms120183010.120 Why?
Head and Neck Neoplasms2201828290.110 Why?
Carcinoma, Squamous Cell2201839840.100 Why?
Oropharyngeal Neoplasms120174750.100 Why?
Human Rights120153000.100 Why?
Lymph Node Excision1201812770.100 Why?
Parotid Neoplasms120131550.100 Why?
Lymphatic Metastasis1201829170.090 Why?
Chemotherapy, Adjuvant1201834760.090 Why?
Neoplasm, Residual120139830.080 Why?
SEER Program1201315120.070 Why?
Lymphoma1201318720.060 Why?
Immunologic Factors1201215680.050 Why?
Antirheumatic Agents1201213490.050 Why?
Kaplan-Meier Estimate3201864530.050 Why?
Parathyroidectomy120222400.050 Why?
Neoplasm Staging32018110640.040 Why?
Chronic Disease1201291140.040 Why?
Thyroidectomy120228960.040 Why?
Arthritis, Rheumatoid1201237300.030 Why?
Neoplasm Recurrence, Local1201391720.030 Why?
Drug Therapy120174990.030 Why?
Treatment Outcome32018636640.030 Why?
Humans920227460700.030 Why?
Prognosis32018290720.020 Why?
Survival Rate22018126320.020 Why?
Papillomaviridae1201711000.020 Why?
Proportional Hazards Models22018122720.020 Why?
Female620183821290.020 Why?
Propensity Score1201818480.020 Why?
Middle Aged520182144190.020 Why?
Follow-Up Studies12012387520.020 Why?
Tomography, X-Ray Computed12013201450.020 Why?
Young Adult22013571140.020 Why?
Retrospective Studies42018782930.020 Why?
Sex Distribution1201322580.020 Why?
Male520183510980.020 Why?
Age Distribution1201328420.020 Why?
Combined Modality Therapy1201885090.020 Why?
Magnetic Resonance Imaging12013357810.020 Why?
Survival Analysis12018101270.020 Why?
Aged420181642220.010 Why?
Disease-Free Survival1201367810.010 Why?
Incidence12013208120.010 Why?
Infant, Newborn12013257530.010 Why?
Infant12013354480.010 Why?
Child, Preschool12013413830.010 Why?
Aged, 80 and over12013575520.000 Why?
United States12013703680.000 Why?
Child12013784690.000 Why?
Adolescent12013862120.000 Why?
Adult120132149690.000 Why?
Otremba's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (71)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.